155 related articles for article (PubMed ID: 31841869)
21. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
Poulin P; Theil FP
J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
[TBL] [Abstract][Full Text] [Related]
22. Physiologically based pharmacokinetic model for quinocetone in pigs and extrapolation to mequindox.
Zhu X; Huang L; Xu Y; Xie S; Pan Y; Chen D; Liu Z; Yuan Z
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2017 Feb; 34(2):192-210. PubMed ID: 28001497
[TBL] [Abstract][Full Text] [Related]
23. Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling.
Lin Z; Aryal S; Cheng YH; Gesquiere AJ
ACS Nano; 2022 Dec; 16(12):19722-19754. PubMed ID: 36520546
[TBL] [Abstract][Full Text] [Related]
24. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
[TBL] [Abstract][Full Text] [Related]
25. The use of physiologically based models to integrate diverse data sets and reduce uncertainty in the prediction of perchlorate and iodide kinetics across life stages and species.
Clewell RA; Merrill EA; Robinson PJ
Toxicol Ind Health; 2001 Jun; 17(5-10):210-22. PubMed ID: 12539865
[TBL] [Abstract][Full Text] [Related]
26. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410
[TBL] [Abstract][Full Text] [Related]
27. Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1.
Khot A; Tibbitts J; Rock D; Shah DK
AAPS J; 2017 Nov; 19(6):1715-1734. PubMed ID: 28808917
[TBL] [Abstract][Full Text] [Related]
28. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
Andersen ME
Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
[TBL] [Abstract][Full Text] [Related]
29. Permitted Daily Exposure of the Androgen Receptor Antagonist Flutamide.
Zacharia LC
Toxicol Sci; 2017 Oct; 159(2):279-289. PubMed ID: 28666357
[TBL] [Abstract][Full Text] [Related]
30. PBPK model reporting template for chemical risk assessment applications.
Tan YM; Chan M; Chukwudebe A; Domoradzki J; Fisher J; Hack CE; Hinderliter P; Hirasawa K; Leonard J; Lumen A; Paini A; Qian H; Ruiz P; Wambaugh J; Zhang F; Embry M
Regul Toxicol Pharmacol; 2020 Aug; 115():104691. PubMed ID: 32502513
[TBL] [Abstract][Full Text] [Related]
31. Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.
Mallick P; Song G; Efremenko AY; Pendse SN; Creek MR; Osimitz TG; Hines RN; Hinderliter P; Clewell HJ; Lake BG; Yoon M; Moreau M
Toxicol Sci; 2020 Aug; 176(2):460-469. PubMed ID: 32421774
[TBL] [Abstract][Full Text] [Related]
32. Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.
Troutman JA; Rick DL; Stuard SB; Fisher J; Bartels MJ
Regul Toxicol Pharmacol; 2015 Nov; 73(2):530-43. PubMed ID: 26188115
[TBL] [Abstract][Full Text] [Related]
33. Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate.
Andersen ME; Green T; Frederick CB; Bogdanffy MS
Regul Toxicol Pharmacol; 2002 Dec; 36(3):234-45. PubMed ID: 12473408
[TBL] [Abstract][Full Text] [Related]
34. Human plasma concentrations of trimethylamine N-oxide extrapolated using pharmacokinetic modeling based on metabolic profiles of deuterium-labeled trimethylamine in humanized-liver mice.
Shimizu M; Suemizu H; Mizuno S; Kusama T; Miura T; Uehara S; Yamazaki H
J Toxicol Sci; 2018; 43(6):387-393. PubMed ID: 29877215
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy.
Pierrillas PB; Henin E; Ball K; Ogier J; Amiel M; Kraus-Berthier L; Chenel M; Bouzom F; Tod M
Drug Metab Dispos; 2019 Jun; 47(6):648-656. PubMed ID: 30940629
[TBL] [Abstract][Full Text] [Related]
36. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
37. Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models.
Schroeter JD; Nong A; Yoon M; Taylor MD; Dorman DC; Andersen ME; Clewell HJ
Toxicol Sci; 2011 Apr; 120(2):481-98. PubMed ID: 21205636
[TBL] [Abstract][Full Text] [Related]
38. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
[TBL] [Abstract][Full Text] [Related]
39. Determining tissue distribution of the oral antileishmanial agent miltefosine: a physiologically-based pharmacokinetic modeling approach.
Ramisetty BS; Yang S; Dorlo TPC; Wang MZ
Antimicrob Agents Chemother; 2024 Jun; ():e0032824. PubMed ID: 38842325
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.
Ellison CA
Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
